[Immunosuppression - tough ally in torrid time].

Area of Science:

• Immunology
• Pharmacology
• Medicine

Background:

• Immunosuppression involves a weakened immune response affecting humoral and cellular immunity.
• It leads to deficiencies in antibody classes (IgG, IgM, IgA) and reduced T cell function, impacting cytokine production and cell proliferation.
• Therapeutic immunosuppression is crucial in transplantology, oncology, and autoimmune disease management.

Purpose of the Study:

• To provide a comprehensive overview of immunosuppression, its mechanisms, therapeutic applications, and challenges.
• To discuss various methods of inducing immunosuppression, including surgical, physical, and pharmacological approaches.
• To highlight the side effects of immunosuppression and explore innovative strategies for mitigation and personalized treatment.

Main Methods:

• Review of existing literature on immunosuppression and immunosuppressive agents.
• Analysis of mechanisms underlying immune response inhibition.
• Discussion of therapeutic strategies and emerging treatment modalities.

Main Results:

• Immunosuppression can be induced via organ removal, radiation, or drugs like glucocorticoids, cytostatics, and monoclonal antibodies.
• Side effects include increased infection susceptibility, organ toxicity (nephrotoxicity, neurotoxicity), and potential links to malignancy.
• Drug modification, novel drug development, and controlled-release systems can limit adverse effects.

Conclusions:

• Personalized immunosuppressant treatment tailored to individual genetic profiles offers a promising future direction.
• Balancing therapeutic benefits with manageable side effects is key in immunosuppressive therapy.
• Continued research into novel immunosuppressive agents and delivery methods is essential.